Viewing StudyNCT06126575



Ignite Creation Date: 2024-05-06 @ 7:45 PM
Last Modification Date: 2024-10-26 @ 3:13 PM
Study NCT ID: NCT06126575
Status: RECRUITING
Last Update Posted: 2024-07-10
First Post: 2023-11-06

Brief Title: A PK Study Testing Single Oral Dose of Elacestrant in Subjects With Normal or Severely Impaired Hepatic Function
Sponsor: Stemline Therapeutics Inc
Organization: Stemline Therapeutics Inc

Conditions & Keywords Data

Conditions:
Name
Hepatic Impairment
Keywords:
Name View
elacestrant View
metastatic breast cancer View
breast cancer View